Altered DNA methylation in a severe subtype of idiopathic autism: Evidence for sex differences in affected metabolic pathways

Abstract

Although differences in DNA methylation have been associated with both syndromic and idiopathic autism, differential methylation has not been examined previously with respect to sex differences. The goals of this study were to (1) identify differences in the DNA methylation profiles of lymphoblastoid cell lines derived from a subgroup of severely affected individuals with idiopathic autism and their respective sex-matched siblings, (2) describe autism spectrum disorder–relevant pathways and functions that may be impacted by differentially methylated genes, and (3) investigate sex-dependent differences in methylation patterns and signaling pathways. Our results revealed significant differences in DNA methylation in cells from individuals with idiopathic autism spectrum disorders and from their unaffected sex-matched siblings. The samples were divided either by sex or by separation into discovery and validation groups. The genes in differentially methylated regions were statistically enriched in autism susceptibility genes and canonical pathways commonly associated with autism spectrum disorders, including synaptogenesis, semaphorin, and mammalian target of rapamycin signaling pathways. Differentially methylated region–associated genes in females were additionally associated with pathways that implicate mitochondrial dysfunction and metabolic disorders that may offer some protection against autism spectrum disorders. Further investigations of sex differences are required to develop a fuller understanding of the pathobiology, gene regulatory mechanisms, and differential susceptibility of males and females toward autism spectrum disorders.

Lay abstract

This study investigates altered DNA methylation that may contribute to autism spectrum disorders. DNA methylation is an epigenetic mechanism for regulating the level at which genes are expressed, and is thus complementary to genetics and gene expression analyses which look at the variations in gene structure and gene products in cells. Here, we identify DNA methylation differences between autistic and sex-matched non-autistic siblings, focusing on a subgroup of severely affected individuals with language impairment to reduce the clinical heterogeneity among the cases. Our results show significant differentially methylated genes between the sibling groups that are enriched in autism risk genes as well as in signaling and biochemical pathways previously associated with the pathobiology of autism spectrum disorders. Moreover, we show for the first time that these differences are in part sex dependent, with differentially methylated genes in females associated with pathways that implicate mitochondrial dysfunction and metabolic disorders that may offer some protection to females against autism spectrum disorders. Further investigations of sex differences are required to develop a fuller understanding of the pathobiology, gene regulatory mechanisms, and differential susceptibility of males and females toward autism spectrum disorders.

Keywords

autism spectrum disorder phenotype autism differentially methylated genes DNA methylation lymphoblastoid cells promoter arrays sex differences signaling and metabolic pathways

Get full access to this article

View all access options for this article.

References

Abrahams

B. S.

Arking

D. E.

Campbell

D. B.

Mefford

H. C.

Morrow

E. M.

Weiss

L. A.

. . .Packer

(2013). SFARI gene 2.0: A community-driven knowledgebase for the autism spectrum disorders (ASDs). Molecular Autism, 4(1), Article 36. https://doi.org/10.1186/2040-2392-4-36

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Press.

Andrews

S. V.

Sheppard

Windham

G. C.

Schieve

L. A.

Schendel

D. E.

Croen

L. A.

. . .Ladd-Acosta

(2018). Case-control meta-analysis of blood DNA methylation and autism spectrum disorder. Molecular Autism, 9(1), Article 40. https://doi.org/10.1186/s13229-018-0224-6

Bakulski

K. M.

Halladay

V. W.

Mill

Fallin

M. D.

(2016). Epigenetic research in neuropsychiatric disorders: The “tissue issue.” Current Behavioral Neuroscience Reports, 3, 264–274.

Bakulski

K. M.

Singer

A. B.

Fallin

M. D.

(2014). Genes and environment in autism spectrum disorders: An integrated perspective. In Hu

V. W.

(Ed.), Frontiers in autism research: New horizons for diagnosis and treatment (pp. 335–374). Singapore: World Scientific Publishing Co. https://doi.org/10.1142/9789814602167_0014

Baron

C. A.

Liu

S. Y.

Hicks

Gregg

J. P.

(2006). Utilization of lymphoblastoid cell lines as a system for the molecular modeling of autism. Journal of Autism and Developmental Disorders, 36(8), 973–982. https://doi.org/10.1007/s10803-006-0134-x

Baron-Cohen

Auyeung

Nørgaard-Pedersen

Hougaard

D. M.

Abdallah

M. W.

Melgaard

. . .Lombardo

M. V.

(2014). Elevated fetal steroidogenic activity in autism. Molecular Psychiatry, 20(3), 369–376. https://doi.org/10.1038/mp.2014.48

Baron-Cohen

Knickmeyer

R. C.

Belmonte

M. K.

(2005). Sex differences in the brain: Implications for explaining autism. Science, 310(5749), 819–823. https://doi.org/10.1126/science.1115455

Bell

C. G.

Lowe

Adams

P. D.

Baccarelli

A. A.

Beck

Bell

J. T.

. . .Rakyan

V. K.

(2019). DNA methylation aging clocks: Challenges and recommendations. Genome Biology, 20(1), Article 249. https://doi.org/10.1186/s13059-019-1824-y

10.

Bennuri

S. C.

Rose

Frye

R. E.

(2019). Mitochondrial dysfunction is inducible in lymphoblastoid cell lines from children with autism and may involve the TORC1 pathway. Frontiers in Psychiatry, 10, Article 269. https://doi.org/10.3389/fpsyt.2019.00269

11.

Berko

E. R.

Suzuki

Beren

Lemetre

Alaimo

C. M.

Calder

R. B.

. . .Greally

J. M.

(2014). Mosaic epigenetic dysregulation of ectodermal cells in autism spectrum disorder. PLOS Genetics, 10(5), Article e1004402. https://doi.org/10.1371/journal.pgen.1004402

12.

Bölte

Girdler

Marschik

P. B.

(2019). The contribution of environmental exposure to the etiology of autism spectrum disorder. Cellular and Molecular Life Sciences, 76(7), 1275–1297. https://doi.org/10.1007/s00018-018-2988-4

13.

Brandenburg-Goddard

M. N.

Van Rijn

Rombouts

S. A. R. B.

Veer

I. M.

Swaab

(2013). A comparison of neural correlates underlying social cognition in Klinefelter syndrome and autism. Social Cognitive and Affective Neuroscience, 9(12), 1926–1933. https://doi.org/10.1093/scan/nst190

14.

Bruining

Swaab

Kas

Van Engeland

(2009). Psychiatric characteristics in a self-selected sample of boys with Klinefelter syndrome. Pediatrics, 123(5), e865–e870. https://doi.org/10.1542/peds.2008-1954

15.

Butler

M. G.

Dazouki

M. J.

Zhou

X.-P.

Talebizadeh

Brown

Takahashi

T. N.

. . .Eng

(2005). Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. Journal of Medical Genetics, 42(4), 318–321. https://doi.org/10.1136/jmg.2004.024646

16.

Cheng

Quinn

J. F.

Weiss

L. A.

(2013). An eQTL mapping approach reveals that rare variants in the SEMA5A regulatory network impact autism risk. Human Molecular Genetics, 22(14), 2960–2972. https://doi.org/10.1093/hmg/ddt150

17.

Cherskov

Pohl

Allison

Zhang

Payne

R. A.

Baron-Cohen

(2018). Polycystic ovary syndrome and autism: A test of the prenatal sex steroid theory. Translational Psychiatry, 8(1), Article 136. https://doi.org/10.1038/s41398-018-0186-7

18.

Ciernia

A. V.

LaSalle

(2016). The landscape of DNA methylation amid a perfect storm of autism aetiologies. Nature Reviews Neuroscience, 17(7), 411–423. https://doi.org/10.1038/nrn.2016.41

19.

Clark-Taylor

B. E.

(2004). Is autism a disorder of fatty acid metabolism? possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase. Medical Hypotheses, 62(6), 970–975. https://doi.org/10.1016/j.mehy.2004.01.011

20.

Cline

(2005). Synaptogenesis: A balancing act between excitation and inhibition. Current Biology, 15(6), R203–R205. https://doi.org/10.1016/j.cub.2005.03.010

21.

Crews

Gillette

Scarpino

S. V.

Manikkam

Savenkova

M. I.

Skinner

M. K.

(2012). Epigenetic transgenerational inheritance of altered stress responses. Proceedings of the National Academy of Sciences of the United States of America, 109(23), 9143–9148. https://doi.org/10.1073/pnas.1118514109

22.

Degano

A. L.

Pasterkamp

R. J.

Ronnett

G. V.

(2009). MeCP2 deficiency disrupts axonal guidance, fasciculation, and targeting by altering semaphorin 3F function. Molecular and Cellular Neuroscience, 42(3), 243–254. https://doi.org/10.1016/j.mcn.2009.07.009

23.

Duan

Wang

S.-H.

Song

Mironova

Ming

Kolodkin

A. L.

Giger

R. J.

(2014). Semaphorin 5A inhibits synaptogenesis in early postnatal- and adult-born hippocampal dentate granule cells. eLife, 3, Article e04390. https://doi.org/10.7554/eLife.04390

24.

El-Maouche

Arlt

Merke

D. P.

(2017). Congenital adrenal hyperplasia. The Lancet, 390(10108), 2194–2210. https://doi.org/10.1016/S0140-6736(17)31431-9

25.

Endersby

Baker

S. J.

(2008). PTEN signaling in brain: Neuropathology and tumorigenesis. Oncogene, 27(41), 5416–5430. https://doi.org/10.1038/onc.2008.239

26.

Enstrom

A. M.

Lit

Onore

C. E.

Gregg

J. P.

Hansen

R. L.

Pessah

I. N.

. . .Ashwood

(2009). Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain, Behavior, and Immunity, 23(1), 124–133. https://doi.org/10.1016/j.bbi.2008.08.001

27.

Feinberg

J. I.

Bakulski

K. M.

Jaffe

A. E.

Tryggvadottir

Brown

S. C.

Goldman

L. R.

. . .Feinberg

A. P.

(2015). Paternal sperm DNA methylation associated with early signs of autism risk in an autism-enriched cohort. International Journal of Epidemiology, 44, 1199–1210. https://doi.org/10.1093/ije/dyv028

28.

Ferri

S. L.

Abel

Brodkin

E. S.

(2018). Sex differences in autism spectrum disorder: A review. Current Psychiatry Reports, 20(2), Article 9. https://doi.org/10.1007/s11920-018-0874-2

29.

Frias

C. P.

Liang

Bresser

Scheefhals

Van Kesteren

Van Dorland

. . .Wierenga

C. J.

(2019). Semaphorin4D induces inhibitory synapse formation by rapid stabilization of presynaptic boutons via MET coactivation. Journal of Neuroscience, 39(22), 4221–4237. https://doi.org/10.1523/JNEUROSCI.0215-19.2019

30.

Frye

R. E.

Melnyk

Macfabe

D. F.

(2013). Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder. Translational Psychiatry, 3, Article e220. https://doi.org/10.1038/tp.2012.143

31.

Ganesan

Balasubramanian

Mahalaxmi

Venugopal

Subramaniam

M. D.

Cho

S.-G.

Vellingiri

(2019). mTOR signalling pathway: A root cause for idiopathic autism? BMB Reports, 52(7), 424–433.

32.

Gaugler

Klei

Sanders

S. J.

Bodea

C. A.

Goldberg

A. P.

Lee

A. B.

. . .Buxbaum

J. D.

(2014). Most genetic risk for autism resides with common variation. Nature Genetics, 46(8), 881–885. https://doi.org/10.1038/ng.3039

33.

Gilbert

Man

H.-Y.

(2017). Fundamental elements in autism: From neurogenesis and neurite growth to synaptic plasticity. Frontiers in Cellular Neuroscience, 11, Article 359. https://doi.org/10.3389/fncel.2017.00359

34.

Ginsberg

M. R.

Rubin

R. A.

Falcone

Ting

A. H.

Natowicz

M. R.

(2012). Brain transcriptional and epigenetic associations with autism. PLOS ONE, 7(9), Article e44736. https://doi.org/10.1371/journal.pone.0044736

35.

Glatt

S. J.

Tsuang

M. T.

Winn

Chandler

S. D.

Collins

Lopez

. . .Courchesne

(2012). Blood-based gene expression signatures of infants and toddlers with autism. Journal of the American Academy of Child and Adolescent Psychiatry, 51(9), 934–944.e2. https://doi.org/10.1016/j.jaac.2012.07.007

36.

Gogos

Sbisa

A. M.

Sun

Gibbons

Udawela

Dean

(2015). A role for estrogen in schizophrenia: Clinical and preclinical findings. International Journal of Endocrinology, 2015, Article 615356. https://doi.org/10.1155/2015/615356

37.

Gregg

J. P.

Lit

Baron

C. A.

Hertz-Picciotto

Walker

Davis

R. A.

. . .Sharp

F. R.

(2008). Gene expression changes in children with autism. Genomics, 91(1), 22–29. https://doi.org/10.1016/j.ygeno.2007.09.003

38.

Guang

Pang

Deng

Yang

. . .Peng

(2018). Synaptopathology involved in autism spectrum disorder. Frontiers in Cellular Neuroscience, 12, Article 470. https://doi.org/10.3389/fncel.2018.00470

39.

Gui

Jones

E. J. H.

Wong

C. C. Y.

Meaburn

Xia

Pasco

. . .Johnson

M. H.

(2020). Leveraging epigenetics to examine differences in developmental trajectories of social attention: A proof-of-principle study of DNA methylation in infants with older siblings with autism. Infant Behavior and Development, 60, Article 101409. https://doi.org/10.1016/j.infbeh.2019.101409

40.

Hannon

Schendel

Ladd-Acosta

Grove

Hansen

C. S.

Andrews

S. V.

. . .Walters

(2018). Elevated polygenic burden for autism is associated with differential DNA methylation at birth. Genome Medicine, 10(1), Article 19. https://doi.org/10.1186/s13073-018-0527-4

41.

Hochberg

(1988). A sharper Bonferroni procedure for multiple tests of significance. Biometrika, 75(4), 800–802. https://doi.org/10.1093/biomet/75.4.800

42.

Hou

Syn

W.-K.

(2018). Role of metabolism in hepatic stellate cell activation and fibrogenesis. Frontiers in Cell and Developmental Biology, 6, Article 150. https://doi.org/10.3389/fcell.2018.00150

43.

V. W.

(2013a). The expanding genomic landscape of autism spectrum disorders: Discovering the “forest” beyond the “trees.” Future Neurology, 8(1), 29–42. https://doi.org/10.2217/fnl.12.83

44.

V. W.

(2013b). From genes to environment: Using integrative genomics to build a “systems level” understanding of autism spectrum disorders. Child Development, 84(1), 89–103. https://doi.org/10.1111/j.1467-8624.2012.01759.x

45.

V. W.

Addington

Hyman

(2011). Novel autism subtype-dependent genetic variants are revealed by quantitative trait and subphenotype association analyses of published GWAS data. PLOS ONE, 6(4), Article e19067. https://doi.org/10.1371/journal.pone.0019067

46.

V. W.

Frank

B. C.

Heine

Lee

N. H.

Quackenbush

(2006). Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes. BMC Genomics, 7, Article 118. https://doi.org/10.1186/1471-2164-7-118

47.

V. W.

Lai

(2013). Developing a predictive gene classifier for autism spectrum disorders based upon differential gene expression profiles of phenotypic subgroups. North American Journal of Medicine and Science, 6(3), 107–116. https://doi.org/10.7156/najms.2013.0603107

48.

V. W.

Nguyen

Kim

K. S.

Steinberg

M. E.

Sarachana

Scully

M. A.

. . .Lee

N. H.

(2009). Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: Altered pathways in neuronal development and steroid biosynthesis. PLOS ONE, 4(6), Article e5775. https://doi.org/10.1371/journal.pone.0005775

49.

V. W.

Sarachana

Kim

K. S.

Nguyen

Kulkarni

Steinberg

M. E.

. . .Lee

N. H.

(2009). Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: Evidence for circadian rhythm dysfunction in severe autism. Autism Research: Official Journal of the International Society for Autism Research, 2(2), 78–97. https://doi.org/10.1002/aur.73

50.

V. W.

Sarachana

Sherrard

R. M.

Kocher

K. M.

(2015). Investigation of sex differences in the expression of RORA and its transcriptional targets in the brain as a potential contributor to the sex bias in autism. Molecular Autism, 6, Article 7. https://doi.org/10.1186/2040-2392-6-7

51.

V. W.

Steinberg

M. E.

(2009). Novel clustering of items from the autism diagnostic interview-revised to define phenotypes within autism spectrum disorders. Autism Research: Official Journal of the International Society for Autism Research, 2(2), 67–77. https://doi.org/10.1002/aur.72

52.

Iossifov

O’Roak

B. J.

Sanders

S. J.

Ronemus

Krumm

Levy

. . .Wigler

(2014). The contribution of de novo coding mutations to autism spectrum disorder. Nature, 515(7526), 216–221. https://doi.org/10.1038/nature13908

53.

Johnson

W. E.

Meyer

C. A.

Gottardo

Carroll

J. S.

Brown

Liu

X. S.

(2006). Model-based analysis of tiling-arrays for ChIP-chip. Proceedings of the National Academy of Sciences of the United States of America, 103(33), 12457–12462. https://doi.org/10.1073/pnas.0601180103

54.

Katsigianni

Karageorgiou

Lambrinoudaki

Siristatidis

(2019). Maternal polycystic ovarian syndrome in autism spectrum disorder: A systematic review and meta-analysis. Molecular Psychiatry, 24(12), 1787–1797. https://doi.org/10.1038/s41380-019-0398-0

55.

Kim

Jho

E.-H.

(2014). Cross-talk between wnt/β-catenin and hippo signaling pathways: A brief review. BMB Reports, 47(10), 540–545. https://doi.org/10.5483/BMBRep.2014.47.10.177

56.

Knickmeyer

Baron-Cohen

Fane

B. A.

Wheelwright

Mathews

G. A.

Conway

G. S.

. . .Hines

2006). Androgens and autistic traits: A study of individuals with congenital adrenal hyperplasia. Hormones and Behavior, 50(1), 148–153. https://doi.org/10.1016/j.yhbeh.2006.02.006

57.

Kong

S. W.

Collins

C. D.

Shimizu-Motohashi

Holm

I. A.

Campbell

M. G.

Lee

I.-H.

. . .Kohane

I. S.

(2012). Characteristics and predictive value of blood transcriptome signature in males with autism spectrum disorders. PLOS ONE, 7(12), Article e49475. https://doi.org/10.1371/journal.pone.0049475

58.

Kraan

C. M.

Godler

D. E.

Amor

D. J.

(2019). Epigenetics of fragile X syndrome and fragile X-related disorders. Developmental Medicine and Child Neurology, 61(2), 121–127. https://doi.org/10.1111/dmcn.13985

59.

Kumar

Reynolds

Rai

Zhou

C. J.

(2019). Impaired neurodevelopmental pathways in autism spectrum disorder: A review of signaling mechanisms and crosstalk. Journal of Neurodevelopmental Disorders, 11(1), Article 10. https://doi.org/10.1186/s11689-019-9268-y

60.

Kung

K. T. F.

Spencer

Pasterski

Neufeld

Glover

O’Connor

T. G.

. . .Hines

(2016). No relationship between prenatal androgen exposure and autistic traits: Convergent evidence from studies of children with congenital adrenal hyperplasia and of amniotic testosterone concentrations in typically developing children. Journal of Child Psychology and Psychiatry and Allied Disciplines, 57(12), 1455–1462. https://doi.org/10.1111/jcpp.12602

61.

Kurata

Shirai

Saito

Okazaki

Ohno

Oguri

. . .Maegaki

(2018). Neurodevelopmental disorders in children with macrocephaly: A prevalence study and PTEN gene analysis. Brain and Development, 40(1), 36–41. https://doi.org/10.1016/j.braindev.2017.07.005

62.

Ladd-Acosta

Hansen

K. D.

Briem

Fallin

M. D.

Kaufmann

W. E.

Feinberg

A. P.

(2014). Common DNA methylation alterations in multiple brain regions in autism. Molecular Psychiatry, 19(8), 862–871. https://doi.org/10.1038/mp.2013.114

63.

Langfelder

Horvath

(2008). WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics, 9, Article 559. https://doi.org/10.1186/1471-2105-9-559

64.

Lavery

L. A.

Zoghbi

H. Y.

(2019). The distinct methylation landscape of maturing neurons and its role in Rett syndrome pathogenesis. Current Opinion in Neurobiology, 59, 180–188. https://doi.org/10.1016/j.conb.2019.08.001

65.

Lee

E. C.

V. W.

(2020). Phenotypic subtyping and re-analysis of existing methylation data from autistic probands in simplex families reveal ASD subtype-associated differentially methylated genes and biological functions. International Journal of Molecular Sciences, 21(18), 1–23. https://doi.org/10.3390/ijms21186877

66.

Leslie

N. R.

Longy

(2016). Inherited PTEN mutations and the prediction of phenotype. Seminars in Cell and Developmental Biology, 52, 30–38. https://doi.org/10.1016/j.semcdb.2016.01.030

67.

Liang

Wang

Yang

Zhan

. . .Wu

(2019). Genome-wide DNA methylation analysis reveals epigenetic pattern of SH2B1 in Chinese monozygotic twins discordant for autism spectrum disorder. Frontiers in Neuroscience, 13, Article 712. https://doi.org/10.3389/fnins.2019.00712

68.

Liu

Shi

(2015). Regulation of estrogen receptor expression in the hypothalamus by sex steroids: Implication in the regulation of energy homeostasis. International Journal of Endocrinology, 2015, Article 949085. https://doi.org/10.1155/2015/949085

69.

Massrali

Brunel

Hannon

Wong

Baron-Cohen

Warrier

(2019). Integrated genetic and methylomic analyses identify shared biology between autism and autistic traits. Molecular Autism, 10(1), Article 31. https://doi.org/10.1186/s13229-019-0279-z

70.

Matsuda

K. I.

(2014). Epigenetic changes in the estrogen receptor α gene promoter: Implications in sociosexual behaviors. Frontiers in Neuroscience, 8, Article 344. https://doi.org/10.3389/fnins.2014.00344

71.

Matsuda

K. I.

Mori

Kawata

(2012). Epigenetic mechanisms are involved in sexual differentiation of the brain. Reviews in Endocrine and Metabolic Disorders, 13(3), 163–171. https://doi.org/10.1007/s11154-012-9202-z

72.

Mauvais-Jarvis

(2015). Sex differences in metabolic homeostasis, diabetes, and obesity. Biology of Sex Differences, 6(1), 3–8. https://doi.org/10.1186/s13293-015-0033-y

73.

McBirney

King

S. E.

Pappalardo

Houser

Unkefer

Nilsson

. . .Skinner

M. K.

(2017). Atrazine induced epigenetic transgenerational inheritance of disease, lean phenotype and sperm epimutation pathology biomarkers. PLOS ONE, 12, Article e0184306. https://doi.org/10.1371/journal.pone.0184306

74.

Melin

Carlsson

Anckarsater

Rastam

Betancur

Isaksson

. . .Dahl

(2006). Constitutional downregulation of SEMA5A expression in autism. Neuropsychobiology, 54(1), 64–69. https://doi.org/10.1159/000096040

75.

Modabbernia

Velthorst

Reichenberg

(2017). Environmental risk factors for autism: An evidence-based review of systematic reviews and meta-analyses. Molecular Autism, 8(1), Article 13. https://doi.org/10.1186/s13229-017-0121-4

76.

Moosa

Shu

Sarachana

V. W.

(2018). Are endocrine disrupting compounds environmental risk factors for autism spectrum disorder? Hormones and Behavior, 101, 13–21. https://doi.org/10.1016/j.yhbeh.2017.10.003

77.

Mosca-Boidron

A.-L.

Gueneau

Huguet

Goldenberg

Henry

Gigot

. . .Bourgeron

(2016). A de novo microdeletion of SEMA5A in a boy with autism spectrum disorder and intellectual disability. European Journal of Human Genetics, 24(6), 838–843. https://doi.org/10.1038/ejhg.2015.211

78.

Myers

S. M.

Challman

T. D.

Bernier

Bourgeron

Chung

W. K.

Constantino

J. N.

. . .Ledbetter

D. H.

(2020). Insufficient evidence for “Autism-specific” genes. American Journal of Human Genetics, 106(5), 587–595. https://doi.org/10.1016/j.ajhg.2020.04.004

79.

Nardone

Sharan Sams

Reuveni

Getselter

Oron

Karpuj

Elliott

(2014). DNA methylation analysis of the autistic brain reveals multiple dysregulated biological pathways. Translational Psychiatry, 4, Article e433. https://doi.org/10.1038/tp.2014.70

80.

Nguyen

Rauch

T. A.

Pfeifer

G. P.

V. W.

(2010). Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. The FASEB Journal, 24(8), 3036–3051. https://doi.org/10.1096/fj.10-154484

81.

Nguyen

R. L.

Medvedeva

Y. V.

Ayyagari

T. E.

Schmunk

Gargus

J. J.

(2018). Intracellular calcium dysregulation in autism spectrum disorder: An analysis of converging organelle signaling pathways. Biochimica et Biophysica Acta—Molecular Cell Research, 1865(11), 1718–1732. https://doi.org/10.1016/j.bbamcr.2018.08.003

82.

Nishimura

Martin

C. L.

Vazquez-Lopez

Spence

S. J.

Alvarez-Retuerto

A. I.

Sigman

. . .Geschwind

D. H.

(2007). Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Human Molecular Genetics, 16(14), 1682–1698. https://doi.org/10.1093/hmg/ddm116

83.

Novarino

El-Fishawy

Kayserili

Meguid

N. A.

Scott

E. M.

Schroth

. . .Gleeson

J. G.

(2012). Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy. Science, 338(6105), 394–397. https://doi.org/10.1126/science.1224631

84.

Nugent

B. M.

Wright

C. L.

Shetty

A. C.

Hodes

G. E.

Lenz

K. M.

Mahurkar

. . .McCarthy

M. M.

(2015). Brain feminization requires active repression of masculinization via DNA methylation. Nature Neuroscience, 18(5), 690–697. https://doi.org/10.1038/nn.3988

85.

Ohta

Katsuda

Miyajima

Sasase

Kimura

Tong

Yamada

(2014). Gender differences in metabolic disorders and related diseases in spontaneously diabetic Torii-Lepr(fa) rats. Journal of Diabetes Research, 2014, Article 841957. https://doi.org/10.1155/2014/841957

86.

Oliveros

J. C.

(2007). Venny. An interactive tool for comparing lists with Venn’s diagrams. http://bioinfogp.cnb.csic.es/tools/venny/index.html

87.

Omran

Christian

(2020). Inflammatory signaling and brown fat activity. Frontiers in Endocrinology, 11, Article 156. https://doi.org/10.3389/fendo.2020.00156

88.

Panjwani

A. A.

Fahey

J. W.

Palmer

Wang

Hong

. . .Wang

(2019). Maternal obesity/diabetes, plasma branched-chain amino acids, and autism spectrum disorder risk in urban low-income children: Evidence of sex difference. Autism Research, 12(10), 1562–1573. https://doi.org/10.1002/aur.2177

89.

Parikshak

N. N.

Luo

Zhang

Won

Lowe

J. K.

Chandran

. . .Geschwind

D. H.

(2013). Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell, 155(5), Article 1008. https://doi.org/10.1016/j.cell.2013.10.031

90.

Persico

A. M.

Bourgeron

(2006). Searching for ways out of the autism maze: Genetic, epigenetic and environmental clues. Trends in Neurosciences, 29(7), 349–358. https://doi.org/10.1016/j.tins.2006.05.010

91.

Pinto

Delaby

Merico

Barbosa

Merikangas

Klei

. . .Scherer

S. W.

(2014). Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. American Journal of Human Genetics, 94(5), 677–694. https://doi.org/10.1016/j.ajhg.2014.03.018

92.

Rademacher

Eickholt

B. J.

(2019). PTEN in autism and neurodevelopmental disorders. Cold Spring Harbor Perspectives in Medicine, 9(11), Article a036780. https://doi.org/10.1101/cshperspect.a036780

93.

Richards

J. E.

Reynolds

G. D.

Courage

M. L.

(2010). The neural bases of infant attention. Current Directions in Psychological Science, 19(1), 41–46. https://doi.org/10.1177/0963721409360003

94.

Ridley

(2019). Some difficulties behind the concept of the “Extreme male brain” in autism research. A theoretical review. Research in Autism Spectrum Disorders, 57, 19–27. https://doi.org/10.1016/j.rasd.2018.09.007

95.

Rose

Niyazov

D. M.

Rossignol

D. A.

Goldenthal

Kahler

S. G.

Frye

R. E.

(2018). Clinical and molecular characteristics of mitochondrial dysfunction in autism spectrum disorder. Molecular Diagnosis and Therapy, 22(5), 571–593. https://doi.org/10.1007/s40291-018-0352-x

96.

Rosina

Battan

Siracusano

Di Criscio

Hollis

Pacini

. . .Bagni

(2019). Disruption of mTOR and MAPK pathways correlates with severity in idiopathic autism. Translational Psychiatry, 9(1), Article 50. https://doi.org/10.1038/s41398-018-0335-z

97.

Ruzzo

E. K.

Pérez-Cano

Jung

J.-Y.

Wang

L.-K.

Kashef-Haghighi

Hartl

. . .Wall

D. P.

(2019). Inherited and de novo genetic risk for autism impacts shared networks. Cell, 178(4), 850–866.e26. https://doi.org/10.1016/j.cell.2019.07.015

98.

Saeliw

Tangsuwansri

Thongkorn

Chonchaiya

Suphapeetiporn

Mutirangura

. . .Sarachana

(2018). Integrated genome-wide Alu methylation and transcriptome profiling analyses reveal novel epigenetic regulatory networks associated with autism spectrum disorder. Molecular Autism, 9, Article 27. https://doi.org/10.6084/m9.figshare.c.4071464

99.

Saffari

Arno

Nasser

Ronald

Wong

C. C. Y.

Schalkwyk

L. C.

. . .Meaburn

E. L.

(2019). RNA sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation. Molecular Autism, 10(1), Article 38. https://doi.org/10.1186/s13229-019-0285-1

100.

Sarachana

V. W.

(2013a). Differential recruitment of coregulators to the RORA promoter adds another layer of complexity to gene (dys) regulation by sex hormones in autism. Molecular Autism, 4(1), Article 39. https://doi.org/10.1186/2040-2392-4-39

101.

Sarachana

V. W.

(2013b). Genome-wide identification of transcriptional targets of RORA reveals direct regulation of multiple genes associated with autism spectrum disorder. Molecular Autism, 4(1), Article 14. https://doi.org/10.1186/2040-2392-4-14

102.

Sarachana

R.-C.

V. W.

(2011). Sex hormones in autism: Androgens and estrogens differentially and reciprocally regulate RORA, a novel candidate gene for autism. PLOS ONE, 6(2), Article e17116. https://doi.org/10.1371/journal.pone.0017116

103.

Schaafsma

S. M.

Pfaff

D. W.

(2014). Etiologies underlying sex differences in autism spectrum disorders. Frontiers in Neuroendocrinology, 35(3), 255–271. https://doi.org/10.1016/j.yfrne.2014.03.006

104.

Schnoor

Alcaide

Voisin

M.-B.

Van Buul

J. D.

(2015). Crossing the vascular wall: Common and unique mechanisms exploited by different leukocyte subsets during extravasation. Mediators of Inflammation, 2015, Article 946509. https://doi.org/10.1155/2015/946509

105.

Siu

M. T.

Butcher

D. T.

Turinsky

A. L.

Cytrynbaum

Stavropoulos

D. J.

Walker

. . .Weksberg

(2019). Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants. Clinical Epigenetics, 11(1), Article 103. https://doi.org/10.1186/s13148-019-0684-3

106.

Siu

M. T.

Weksberg

(2017). Epigenetics of autism spectrum disorder. In Delgado-Morales

(Ed.), Neuroepigenomics in aging and disease (pp. 63–90). Springer International Publishing. https://doi.org/10.1007/978-3-319-53889-1_4

107.

Skinner

M. K.

Savenkova

M. I.

Zhang

Gore

A. C.

Crews

(2014). Gene bionetworks involved in the epigenetic transgenerational inheritance of altered mate preference: Environmental epigenetics and evolutionary biology. BMC Genomics, 15(1), Article 377. https://doi.org/10.1186/1471-2164-15-377

108.

Spinelli

Black

F. M.

Berg

J. N.

Eickholt

B. J.

Leslie

N. R.

(2015). Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes. Journal of Medical Genetics, 52(2), 128–134. https://doi.org/10.1136/jmedgenet-2014-102803

109.

Talebizadeh

Arking

D. E.

V. W.

(2013). A novel stratification method in linkage studies to address inter and intra family heterogeneity in autism. PLOS ONE, 8(6), Article e67569. https://doi.org/10.1371/journal.pone.0067569

110.

Tangsuwansri

Saeliw

Thongkorn

Chonchaiya

Suphapeetiporn

Mutirangura

. . .Sarachana

(2018). Investigation of epigenetic regulatory networks associated with autism spectrum disorder (ASD) by integrated global LINE-1 methylation and gene expression profiling analyses. PLOS ONE, 13(7), Article e0201071. https://doi.org/10.1371/journal.pone.0201071

111.

Tremblay

M. W.

Jiang

(2019). DNA methylation and susceptibility to autism spectrum disorder. Annual Review of Medicine, 70(1), Article 151. https://doi.org/10.1146/annurev-med-120417-091431

112.

Tsang

Ahmad

Mat

Zhao

Xiao

Xia

Xue

(2016). Variation of global DNA methylation levels with age and in autistic children. Human Genomics, 10(1), Article 31. https://doi.org/10.1186/s40246-016-0086-y

113.

Unnikrishnan

Freeman

W. M.

Jackson

Wren

J. D.

Porter

Richardson

(2019). The role of DNA methylation in epigenetics of aging. Pharmacology and Therapeutics, 195, 172–185. https://doi.org/10.1016/j.pharmthera.2018.11.001

114.

Vorstman

J. A. S.

Parr

J. R.

Moreno-De-Luca

Anney

R. J. L.

Nurnberger

J. I.

Hallmayer

J. F.

(2017). Autism genetics: Opportunities and challenges for clinical translation. Nature Reviews Genetics, 18(6), 362–376. https://doi.org/10.1038/nrg.2017.4

115.

Walker

S. J.

Langefeld

C. D.

Zimmerman

Schwartz

M. Z.

Krigsman

(2019). A molecular biomarker for prediction of clinical outcome in children with ASD, constipation, and intestinal inflammation. Scientific Reports, 9(1), Article 5987. https://doi.org/10.1038/s41598-019-42568-1

116.

Weiss

L. A.

Arking

D. E.

Daly

M. J.

Chakravarti

Brune

C. W.

West

. . .Peltonen

(2009). A genome-wide linkage and association scan reveals novel loci for autism. Nature, 461(7265), 802–808. https://doi.org/10.1038/nature08490

117.

Werling

D. M.

Geschwind

D. H.

(2013). Sex differences in autism spectrum disorders. Current Opinion in Neurology, 26(2), 146–153. https://doi.org/10.1097/WCO.0b013e32835ee548

118.

Winden

K. D.

Ebrahimi-Fakhari

Sahin

(2018). Abnormal mTOR activation in autism. Annual Review of Neuroscience, 41, Article 1. https://doi.org/10.1146/annurev-neuro-080317-061747

119.

Wong

C. C. Y.

Meaburn

E. L.

Ronald

Price

T. S.

Jeffries

A. R.

Schalkwyk

L. C.

. . .Mill

(2014). Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Molecular Psychiatry, 19(4), 495–503. https://doi.org/10.1038/mp.2013.41

120.

Wong

C. C. Y.

Smith

R. G.

Hannon

Ramaswami

Parikshak

N. N.

Assary

. . .Mill

(2019). Genome-wide DNA methylation profiling identifies convergent molecular signatures associated with idiopathic and syndromic autism in post-mortem human brain tissue. Human Molecular Genetics, 28(13), 2201–2211. https://doi.org/10.1093/hmg/ddz052

121.

Xie

Jones

Deeney

J. T.

Hur

S. K.

Bankaitis

V. A.

(2016). Inborn errors of long-chain fatty acid ß-oxidation link neural stem cell self-renewal to autism. Cell Reports, 14(5), 991–999. https://doi.org/10.1016/j.celrep.2016.01.004

122.

Yang

Huang

A. Y.

Zhang

. . .Wei

(2018). AutismKB 2.0: A knowledgebase for the genetic evidence of autism spectrum disorder. Database, 2018, Article bay106. https://doi.org/10.1093/database/bay106

123.

Yoo

(2015). Genetics of autism spectrum disorder: Current status and possible clinical applications. Experimental Neurobiology, 24(4), 257–272. https://doi.org/10.1146/annurev-publhealth-031816-044318

124.

Zhang

Yuan

Wang

(2014). The canonical wnt signaling pathway in autism. CNS and Neurological Disorders—Drug Targets, 13(5), 765–770. https://doi.org/10.2174/1871527312666131223114149

125.

Zhu

Mordaunt

C. E.

Yasui

D. H.

Marathe

Coulson

R. L.

Dunaway

K. W.

. . .Lasalle

J. M.

(2019). Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study. Human Molecular Genetics, 28(16), Article 2659. https://doi.org/10.1093/hmg/ddz084

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.21 MB

0.55 MB

0.01 MB

0.10 MB

0.09 MB

0.02 MB

0.03 MB

0.02 MB

0.10 MB

0.08 MB

0.02 MB

0.01 MB

0.13 MB